Karyopharm Therapeutics
KPTI
KPTI
136 hedge funds and large institutions have $1.31B invested in Karyopharm Therapeutics in 2020 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 56 increasing their positions, 37 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
0.05% more ownership
Funds ownership: 6.26% → 6.31% (+0.05%)
7% less funds holding
Funds holding: 146 → 136 (-10)
20% less first-time investments, than exits
New positions opened: 28 | Existing positions closed: 35
Holders
136
Holding in Top 10
9
Calls
$22.2M
Puts
$21.7M
Top Buyers
| 1 | +$62.5M | |
| 2 | +$39.2M | |
| 3 | +$25.6M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$23.5M |
| 5 |
ACA
Avoro Capital Advisors
New York
|
+$21.1M |
Top Sellers
| 1 | -$15.2M | |
| 2 | -$11.9M | |
| 3 | -$11.3M | |
| 4 |
Two Sigma Investments
New York
|
-$6.06M |
| 5 |
PAI
Palo Alto Investors
Palo Alto,
California
|
-$5.67M |